We are pleased to invite investors and analysts to participate in our virtual event on Monday, 25 November 2024, showcasing how computational biology and AI/ML/LLM get integrated into early drug discovery and drug development following the “lab in a loop” concept. 16:30 – 18:00 CET / 15:30 – 17:00 GMT 10:30 am – 12:00 pm EST / 7:30 – 9:00 am PST The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:30 CET on the day of the event. > click here Agenda Welcome Bruno Eschli, Head of Investor Relations Revolutionizing drug R&D with Lab in a Loop Aviv Regev, Head of Genentech Research and Early Development (gRED) Q&A For the Q&A we will also be joined by John Marioni, Senior Vice President and Head of gRED Computation Access to virtual event (pre-registration required) Please pre-register for our webinar here*.   Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.   A replay of the webcast will be available via > ir.roche.com  *privacy notice   Best regards,

Bruno Eschli Head of Investor Relations	Jon Bayard Investor Relations Officer
Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.